Lower Saxony study shows high quality X-rays:
This article was originally published in Clinica
X-ray diagnostics in the German federal state of Lower Saxony are of extremely high quality, claims the region's doctors association (KVN). Last year, the KVN commissioned a random examination of 143 practices and some 5,500 X-ray results, according to guidelines on "criteria and quality assessment in X-ray diagnostics" from the federal committee of doctors and sickness funds. Results showed that 106 of the practices operated with a high level of quality and received no complaints. A further 36 recorded a low number of complaints, but only one practice was found to be operating at a substandard level. The doctor has been warned by the KVN, which will refuse to reimburse the practice if does not raise its standard within six months.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.